Literature DB >> 16504335

Organic-inorganic hybrid-nanocarrier of siRNA constructing through the self-assembly of calcium phosphate and PEG-based block aniomer.

Yoshinori Kakizawa1, Sanae Furukawa, Atushi Ishii, Kazunori Kataoka.   

Abstract

The development of siRNA delivery systems is a major key for practical RNA therapy that holds promise for the treatment of life-threatening human diseases, yet there still exists significant difficulties in their construction because of the various requirements including high transfection efficacy, tolerability in the biological medium, and low toxicity. Here we report the novel preparation route of organic-inorganic hybrid-nanocarriers entrapping siRNA based on the self-assembly of the block aniomer, poly(ethylene glycol)-block-poly(methacrylic acid), with calcium phosphate crystals. The nanocarriers have diameters in the range of several hundreds of nanometers and revealed excellent colloidal stability due to the steric stabilization effect of the PEG palisade. The biological activity of siRNA loaded in nanocarriers was assessed using 293 cells stably expressing luciferase gene, showing the remarkably high gene silencing-efficacy without the use of any adjuvant molecules such as chroloquin. Further advantage of the system is the serum tolerability, which is of a critical issue in in vivo application.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16504335     DOI: 10.1016/j.jconrel.2006.01.004

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  24 in total

1.  Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung cancer.

Authors:  Yang Yang; Yunxia Hu; Yuhua Wang; Jun Li; Feng Liu; Leaf Huang
Journal:  Mol Pharm       Date:  2012-06-22       Impact factor: 4.939

Review 2.  Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy.

Authors:  Yunching Chen; Leaf Huang
Journal:  Expert Opin Drug Deliv       Date:  2008-12       Impact factor: 6.648

Review 3.  Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.

Authors:  Elias Fattal; Gillian Barratt
Journal:  Br J Pharmacol       Date:  2009-04-02       Impact factor: 8.739

Review 4.  Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery.

Authors:  Kensuke Osada; R James Christie; Kazunori Kataoka
Journal:  J R Soc Interface       Date:  2009-04-01       Impact factor: 4.118

Review 5.  Critical evaluation of in silico methods for prediction of coiled-coil domains in proteins.

Authors:  Chen Li; Catherine Ching Han Chang; Jeremy Nagel; Benjamin T Porebski; Morihiro Hayashida; Tatsuya Akutsu; Jiangning Song; Ashley M Buckle
Journal:  Brief Bioinform       Date:  2015-07-15       Impact factor: 11.622

6.  A facile approach to construct hybrid multi-shell calcium phosphate gene particles.

Authors:  Zhi-xue Xu; Ran Zhang; You-xiang Wang; Qiao-ling Hu
Journal:  J Zhejiang Univ Sci B       Date:  2010-04       Impact factor: 3.066

7.  Diseases originate and terminate by genes: unraveling nonviral gene delivery.

Authors:  Rajan Swami; Indu Singh; Wahid Khan; Sistla Ramakrishna
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

Review 8.  Non-viral nucleic acid containing nanoparticles as cancer therapeutics.

Authors:  Kristen L Kozielski; Yuan Rui; Jordan J Green
Journal:  Expert Opin Drug Deliv       Date:  2016-06-06       Impact factor: 6.648

Review 9.  Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.

Authors:  Srinivas Ramishetti; Leaf Huang
Journal:  Ther Deliv       Date:  2012-12

10.  Histamine-functionalized copolymer micelles as a drug delivery system in 2D and 3D models of breast cancer.

Authors:  Yuning Zhang; Pontus Lundberg; Maren Diether; Christian Porsch; Caroline Janson; Nathaniel A Lynd; Cosimo Ducani; Michael Malkoch; Eva Malmström; Craig J Hawker; Andreas M Nyström
Journal:  J Mater Chem B       Date:  2015-03-28       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.